Loss of heterozygosity at 6p21.3 underlying HLA class I downregulation in gastric cancer

Journal of Experimental and Clinical Cancer Research

Volumn 25, Issue 1, 2006, Pages 115-119

  Wang, X C ^a   Zhang, J Q ^a   Shen, Y Q ^a   Miao, F Q ^a   Xie, Wei ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Gastric cancer; HLA class I antigen; LOH

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN CLASS 1; MONOCLONAL ANTIBODY;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CHROMOSOME 15; CHROMOSOME 6P; CONTROLLED STUDY; DNA FLANKING REGION; DOWN REGULATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROSATELLITE MARKER; PRIORITY JOURNAL; SHORT TANDEM REPEAT; STOMACH CANCER;

CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 6; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; STOMACH NEOPLASMS;

EID: 33646081516     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Sun X.D., Mu R., Zhou Y.S. et al.: Analysis of mortality rate of stomach cancer and its trend in twenty years in China. Zhonghua Zhong Liu Za Zhi 26:4-9, 2004.
2. Ohnmacht G.A., Marincola F.M.: Heterogeneity in expression of human leukocyte antigens and melanoma associated antigens in advanced melanoma. J. Cell. Physiol. 182:332-338, 2000.
3. Finke J., Ferrone S., Frey A., Mufson A., Ochoa A.: Where have all the T cells gone? Mechanisms of immune evasion by tumors. Immunol. Today 20:158-160, 1999.
4. Ikeda H., Lethe B., Lehmann F. et al.: Charcterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity 6:199-208, 1997.
5. Chen H.L., Gabrilovich D., Virmani A. et al.: Structural and functional analysis of beta2 microglobulin abnormalities in human lung and breast cancer. Int. J. Cancer 67:756-63, 1996.
6. Garrido F., Ruiz-Cabello F., Cabrera T. et al.: Implications for immunosurveillance of altered HLA class I phenotype in human tumors. Immunol. Today 18:89-95, 1997.
7. Shen Y.Q., Zhang J.Q., Miao F.Q. et al.: Relationship between the downregulation of HLA class I antigen and clinicopathological significance in gastric cancer. World J. Gastroenterol. 11:3628-3631, 2005
8. Lopez-Nenot M.A., Esteban F., Ferron A. et al.: HLA class I gene expression on human primary tumors and autologous metastases. Br. J. Cancer 59:221-226, 1989.
9. Feenstra M., Veltkamp M., van Kuik J. et al.: HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas. Tissue Antigens 54:235-245, 1999.
10. Ramal L.M., Feenstra M., van der Zwan A.W. et al.: Criteria to define HLA haplotype loss in human solid tumors. Tissue Antigens 55:443-438, 2000.
11. Cabrera T., Lopez-Nevot M.A., Gaforio J.J., Ruiz-Cabello F., Garrido F.: Analysis of HLA expression in human tumor tissues. Cancer. Immunol. Immunother. 52:1-9, 2003.
12. Paschen A., Mendez R.M., Jimenez P. et al.: Complete loss of HLA class I antigen expression on melanoma cells: a result of successive mutational events. Int. J. Cancer 103:759-767, 2003.
13. Koene G.J., Arts-Hilkes Y.H., van der Ven K.J. et al.: High level of chromosome 15 aneuploidy in head and neck squamous cell carcinoma lesions identified by FISH analysis: limited value of beta2-microglobulin LOH analysis. Tissue Antigens 64:452-461, 2004.
14. Koopman L.A., Corver W.E., van der Slik A.R., Giphart M.J., Fleuren G.J.: Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer. J. Exp. Med. 191: 961-976, 2000.
15. Ryschich E., Cebotari O., Fabian O.V. et al.: Loss of heterozygosity in the HLA class I region in human pancreatic cancer. Tissue Antigen 64:696-702, 2004.
16. Chang C.C., Campoli M., Ferrone S.: HLA class I defects in malignant lesions: What have we learned? Keio. J. Med. 52: 220-229, 2003.